According to a recent LinkedIn post from Pyx Health, the company participated in a presentation at the RISE SNP Summit alongside Centene representative Kari Hadley Gilson and Pyx Quality Director Sally Leahy. The post describes how Centene implemented a redesigned diabetic member engagement program that incorporates Pyx Health outreach and support.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The LinkedIn post highlights that the 2025 iteration of this program reportedly achieved a 38% average care gap closure rate in a historically disengaged or under-engaged population, which the post characterizes as a 9-percentage-point improvement over 2024. It also notes that 44% of outreached members completed A1c screening compared with 12% without outreach, with food used as an engagement lever.
For investors, the post suggests growing validation of Pyx Health’s role as an engagement and support partner in value-based care programs, particularly within complex populations served by plans like Centene. If these outcomes prove scalable, they could strengthen Pyx Health’s value proposition in quality improvement and chronic condition management, potentially supporting deeper payer relationships and incremental revenue opportunities.
The described performance metrics may also enhance Pyx Health’s positioning in competitive bids with health plans that are focused on Star ratings, quality bonuses, and medical cost reduction in special needs plans. However, the post does not provide financial terms, contract scope, or durability of results, so investors would likely view this primarily as a directional indicator of product-market fit rather than a definitive signal of near-term revenue impact.